Genome Research in African American Scleroderma Patients (GRASP Study)
- Study HIC#:2000027458
- Last Updated:07/15/2021
The goal of the GRASP Study (Genome Research in African American Scleroderma Patients is to better understand how African American patients are affected by scleroderma. The Yale Scleroderma Program has partnered with Johns Hopkins University and the National Human Genome Research Institute to collect clinical data and blood samples from African American patients diagnosed with scleroderma to achieve this goal.
- Age18 years and older
- Start Date03/17/2020
- End Date12/31/2021
African American patient with Scleroderma/Systemic sclerosis